NeueHealth, Inc. Quality Score

NEUE

⊜ Compare

Quality25

Weak across most dimensions. This doesn't mean avoid, but the burden of proof is on the bull case.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Growth

Revenue Growth

0/100

-12.4%

Below 2%, essentially flat

Cash Flow Growth

0/100

Negative FCF

FCF negative, burning cash after capex

Business Quality & Capital Allocation

Share Dilution

100/100

-97.7%

Shrinking >2%, active buybacks

Margin Trend

100/100

+19.4pp

Expanded 3+pp, strong improvement

Capital Structure

0/100

$69M

Positive debt with no FCF to service it

2021

$1.26B

$205M

2022

$480M

$350M

2023

$94.0M

$400M

2024

$93.0M

$231M

TTM

$146M

$214M

CashDebt

Return on Capital

0/100

-12.2%

Below 8%, may not cover cost of capital

Customize WeightsPremiumAdjust metric weights to match your investment style.Upgrade

SourceQuality score computed from the 10-Q filed 1 Aug 2025, covering the period ending 30 Jun 2025, as reported to the SEC. Data last refreshed 28 Aug 2026. How this is calculated.

Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Hospital & Medical Service Plans · Pick stocks to compare with NEUE

CompareIntrinsic value

TRUPTrupanion Inc.

$33.68+8.21%73

CLOVClover Health Investments, Corp.

$4.69+9.32%61

ALHCAlignment Healthcare, Inc.

$8.14+10.15%65

CNOCNO Financial Group Inc.

$57.73+0.59%71

HRTGHeritage Insurance Holdings, Inc.

$35.73+0.06%84

AGOAssured Guaranty Ltd.

$72.51+1.71%92

EIGEmployers Holdings Inc.

$47.58+0.49%66

HCIHCI Group, Inc.

$202.53+0.42%87

Spot a number that looks wrong? Check it in NEUE's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing NEUE

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.